Wearable Injectors Market Overview

The wearable injectors market was valued at approximately US$ 5,791.23 million in 2019 and is anticipated to grow to US$ 13,880.88 million by 2027, reflecting a compound annual growth rate (CAGR) of 11.6% from 2020 to 2027.

What are Wearable Injectors?

Wearable injectors are innovative drug delivery systems that adhere to the skin, allowing for the subcutaneous administration of larger volumes of medication. Various pharmaceutical and medical device companies have developed these devices, which typically include a reservoir for the drug, a cannula for delivering the medication to the tissue, and a drive system that ensures the correct volume is administered. These injectors are equipped with adhesive materials to secure them to the patient's skin.

Market Growth Factors

The expansion of the wearable injectors market can be attributed to several factors, including:

• Rising prevalence of chronic diseases


• Technological advancements and improvements in design


• Limitations of traditional drug delivery systems

Despite these growth drivers, the market faces challenges, particularly the slow adoption rates in emerging economies. However, the increasing demand for biologics presents a significant opportunity for companies operating in the wearable injectors sector.

Regional Insights

Wearable injectors are gaining traction in various regions, with significant market potential identified in North America, Europe, and Asia Pacific.

Technological Innovations and Design Enhancements

Wearable injectors are becoming increasingly popular due to their ability to deliver high volumes of viscous formulations. The costs associated with intravenous (IV) infusions in healthcare settings are substantial, and self-administration of subcutaneous injections can lead to savings of 30-70%. Additionally, traditional administration methods carry risks such as incorrect dosages and needle stick injuries.

The rise in biologic drugs that cannot be taken orally has further fueled the adoption of wearable injectors. These drugs often require higher dosage volumes and thicker formulations, necessitating alternative delivery methods. For example, the enFuse wearable injector from Enable Injections is designed for the subcutaneous delivery of high-volume therapeutics outside of clinical settings. The company has also introduced mobile monitoring features and enhanced volume capabilities in its devices.

Another notable innovation is the cartridge-based wearable device from Stevanato Group, which won the Best Innovation in Drug Delivery Device award at the Pharmapack Awards in 2019. This device features a disposable pod and a reusable handheld controller, catering to various therapeutic areas such as diabetes, hormone therapies, pain management, and Alzheimer's treatment. Continuous advancements by leading manufacturers are further propelling the demand for wearable injectors.

Product Segmentation

The wearable injectors market is categorized into two main types: on-body injectors and off-body injectors. In 2019, on-body injectors held a larger market share due to their comfort, ease of use, water resistance, and flexible dosing capabilities. They also allow for the automatic warming of refrigerated medications. Conversely, off-body injectors are expected to experience faster growth, as they eliminate risks associated with skin fitting issues and allergic reactions.

End User Segmentation

The market is also segmented by end users, which include hospitals and clinics, homecare settings, and other users. The homecare segment dominated the market in 2019, driven by global trends, the rising incidence of chronic diseases, and advancements in technology. The preference for self-administration and cost-effective healthcare solutions is propelling the growth of this segment. The convenience and accessibility of wearable injectors have made them increasingly popular among patients, leading to greater adoption in homecare environments.

Strategic Insights

Collaborations and technological partnerships among market players are expected to significantly influence the growth of the wearable injectors market in the coming years. Additionally, the increasing number of accidents, trauma cases, and the rising prevalence of infectious diseases are likely to further accelerate market expansion.

Market Segmentation Overview

• By Type:
  
  
  
  • On-body Injectors
  
  
  • Off-body Injectors
  
  
  
  


• By Application:
  
  
  
  • Diabetes
  
  
  • Oncology
  
  
  • Cardiovascular Disease
  
  
  • Autoimmune Disease
  
  
  • Other Applications
  
  
  
  


• By End User:
  
  
  
  • Hospitals and Clinics
  
  
  • Homecare Setting
  
  
  • Other End Users
  
  
  
  


• By Geography:
  
  
  
  • North America
  
  
  • Europe
  
  
  • Asia Pacific
  
  
  • Middle East and Africa
  
  
  • South and Central America
  
  
  
  

Key Players in the Market

• Amgen, Inc.


• Medtronic


• BD


• Insulet Corporation


• Gerresheimer AG (Sensile Medical)


• West Pharmaceutical Services, Inc.


• Ypsomed AG


• Tandem Diabetes Care, Inc.


• Cequr SA


• Debiotech S.A


• E3D Elcam Drug Delivery Devices


• Zealand Pharma A/S (Valeritas, Inc.)